GGrantIndex
← Leaderboards

Timothy J. Griffin

University Of Minnesota

$7,286,622
Attributed
$11,796,495
Total exposure
11
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY200725
$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,796,495 · 11

By mechanism

R01$4,167,082 · 2
R44$2,415,963 · 2
U24$2,392,014 · 1
S10$1,213,085 · 1
U01$787,310 · 1
R21$397,033 · 1

Most similar at University Of Minnesota

Same institution · by research overlap

Others in their field

Top investigators on “Sampling

Research focus

SamplingMass Spectrum AnalysisProteomicsBioinformaticsBaseTechnologyMalignant NeoplasmsResourcesFundingData AnalysesResearch PersonnelCoupledTumorDiagnosisProteinsMultiple OmicsMetabolomicsEnvironmentPathway InteractionsAreaAmino Acid SequenceProgramsGalaxyComplement

Grant awards (28)

The immunoPeptidoGenomic (iPepGen) informatics resource forimmuno-oncology research$386,780
U01 · FY2025 · CA · contact PI
An enabling approach for deep metaproteomic characterization ofmicrobial contributors to tumorigenesis in clinical samples$221,456
R61 · FY2025 · CA · contact PI
Proteogenomics Shared Resource$111,471
P30 · FY2025 · CA · contact PI
The immunoPeptidoGenomic (iPepGen) informatics resource forimmuno-oncology research$400,530
U01 · FY2024 · CA · contact PI
Proteogenomics Shared Resource$79,081
P30 · FY2024 · CA · contact PI
Microbiome-derived regulators of therapy-resistant colorectal tumors$178,483
R21 · FY2023 · CA · contact PI
Microbiome-derived regulators of therapy-resistant colorectal tumors$218,550
R21 · FY2022 · CA · contact PI
Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease$667,118
R01 · FY2021 · HL
A transformative next-generation Orbitrap Tribrid system for the UMN and Upper Midwest$1,213,085
S10 · FY2020 · OD · contact PI
Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease$667,118
R01 · FY2020 · HL
Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease$671,673
R01 · FY2019 · HL
A Galaxy‐based multi‐omic informatics hub for cancer researchers$482,179
U24 · FY2019 · CA · contact PI
Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease$743,025
R01 · FY2018 · HL
Rapid saliva test for diagnostics of Neuro-Cognitive Disorder due to Traumatic Brain Injury (NCDT)$736,575
R44 · FY2018 · HD
A Galaxy‐based multi‐omic informatics hub for cancer researchers$593,249
U24 · FY2018 · CA · contact PI
Rapid oral test for Influenza A+B diagnostics$162,910
R44 · FY2018 · DE
A Galaxy‐based multi‐omic informatics hub for cancer researchers$25,582
U24 · FY2018 · CA · contact PI
US HUPO 2018: Technology accelerating discovery$12,000
R13 · FY2018 · CA · contact PI
Rapid saliva test for diagnostics of Neuro-Cognitive Disorder due to Traumatic Brain Injury (NCDT)$708,335
R44 · FY2017 · HD
A Galaxy‐based multi‐omic informatics hub for cancer researchers$593,835
U24 · FY2017 · CA · contact PI
NEXT-GEN Oral test for monitoring HIV/AIDS in Point-of-Care$374,022
R44 · FY2017 · DE
Expanding multiplexed kinase biosensor analysis to SWATH-MS (Part 2 of 2)$76,417
U24 · FY2017 · CA · contact PI
A Galaxy‐based multi‐omic informatics hub for cancer researchers$620,752
U24 · FY2016 · CA · contact PI
NEXT-GEN Oral test for monitoring HIV/AIDS in Point-of-Care$434,121
R44 · FY2016 · DE
Characterizing Oral Cancer Progression via Saliva Proteomics$350,755
R01 · FY2010 · DE · contact PI
Characterizing Oral Cancer Progression via Saliva Proteomics$354,392
R01 · FY2009 · DE · contact PI
Characterizing Oral Cancer Progression via Saliva Proteomics$354,484
R01 · FY2008 · DE · contact PI
Characterizing Oral Cancer Progression via Saliva Proteomics$358,517
R01 · FY2007 · DE · contact PI